Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone (press release):
Biogen Inc. (Nasdaq: BIIB) today announced a new virtual research study, in collaboration with Apple, to investigate the role Apple Watch and iPhone could play in monitoring cognitive performance and screening for decline in cognitive health including mild cognitive impairment (MCI).
The multi-year, observational research study will be launched later in 2021 and will enroll participants including young and aging adults with a range of cognitive performance. Driven by the powerful technology in Apple Watch and iPhone and Biogen’s in-depth knowledge of neuroscience, the study’s primary objectives are to develop digital biomarkers to help monitor cognitive performance over time and identify early signs of MCI.
For aging adults, cognitive health is becoming increasingly recognized as an important component of overall health. However, significant delays exist in identifying declines in cognitive health including MCI, which impacts approximately 15 – 20 percent of adults over the age of 65. The onset of symptoms is often subtle, ranging from being easily distracted to memory loss, and can take months to years before cognitive decline comes to the attention of health care providers.
“Working in collaboration with Biogen, we hope this study can help the medical community better understand a person’s cognitive performance by simply having them engage with their Apple Watch and iPhone,” said Jeff Williams, Apple’s chief operating officer. “We’re looking forward to learning about the impact our technology can have in delivering better health outcomes through improved detection of declining cognitive health.”
News in Context:
- UCLA launches major mental health study collecting & analyzing data from Apple wearables to better understand depression and anxiety
- Apple/ Eli Lilly’s bet: Wearable and mobile consumer devices may well help us detect cognitive impairment and dementia
- The FDA creates new Digital Health unit to reimagine regulatory paths in the age of scalable, AI-enhanced innovation
- Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
- Mindstrong Health identifies digital biomarkers of cognitive function using smartphone data
- Neurotechnology can improve our lives…if we first address these Privacy and Informed Consent issues